- Home
- PLTK vs QURE Comparison
PLTK vs QURE Comparison
Compare PLTK & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLTK | QURE |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | Israel | Netherlands |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | PLTK | QURE |
|---|---|---|
| Price | $4.12 | $24.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 12 |
| Target Price | $6.61 | ★ $58.55 |
| AVG Volume (30 Days) | 954.0K | ★ 2.8M |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | ★ 9.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $2,726,900,000.00 | $15,751,000.00 |
| Revenue This Year | $9.52 | N/A |
| Revenue Next Year | $2.76 | $158.05 |
| P/E Ratio | $17.65 | ★ N/A |
| Revenue Growth | ★ 7.49 | N/A |
| 52 Week Low | $3.31 | $7.76 |
| 52 Week High | $7.58 | $71.50 |
Technical Indicators
Market Signals| Indicator | PLTK | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 51.26 | 43.66 |
| Support Level | $4.07 | $19.29 |
| Resistance Level | $4.42 | $28.50 |
| Average True Range (ATR) | 0.13 | 1.65 |
| MACD | -0.02 | 0.92 |
| Stochastic Oscillator | 27.38 | 70.10 |
Price Performance
Historical ComparisonAbout PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.